Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of cutaneous medicine and surgery"
DOI: 10.1177/12034754251355595
Abstract: This review summarizes the off-label applications of topical sirolimus (rapamycin) for dermatological conditions beyond its approved use for angiofibromas associated with tuberous sclerosis, focusing on efficacy, safety, and reported adverse effects. Off-label use of mammalian…
read more here.
Keywords:
sirolimus;
label topical;
rapamycin dermatological;
dermatological conditions ... See more keywords